SonoFusion
A New Ultrasound Non-Invasive Surgery Platform
Company Overview
Snapshot
Founded in May 2023, SonoFusion operates with 1–10 employees. The company is currently in the R&D product stage, focusing on developing its innovative ultrasound treatment platform.
Business overview
SonoFusion is a Health Tech & Life Sciences company developing an innovative ultrasound treatment platform. Its core technology combines histotripsy and thermal ablation to deliver precise, non-invasive ultrasound procedures. The company serves the medical devices industry within the broader healthcare and life sciences markets, with a focus on non-invasive diagnostics and ultrasound applications.
Log in to access full profile ›Company Intelligence Q&A
- What is SonoFusion's primary focus?
- SonoFusion is focused on developing an innovative ultrasound treatment platform that combines histotripsy and thermal ablation for precise, non-invasive ultrasound procedures.
- When was SonoFusion founded?
- SonoFusion was founded in May 2023.
- What is the current product stage of SonoFusion?
- SonoFusion's product, an innovative ultrasound treatment platform, is currently in the Research and Development (R&D) stage, focusing on advancing its core technology.
- What markets does SonoFusion target?
- SonoFusion targets geomarkets including Middle Africa, Europe, North America, and Asia, focusing on the medical devices industry.
- What is SonoFusion's business model?
- SonoFusion operates on a B2B business model.